The First Year Experience of Newborn Screening for Pompe Disease in California
Open Access
- 7 February 2020
- journal article
- research article
- Published by MDPI AG in International Journal of Neonatal Screening
- Vol. 6 (1), 9
- https://doi.org/10.3390/ijns6010009
Abstract
The California Department of Public Health started universal newborn screening for Pompe disease in August 2018 with a two-tier process including: (1) acid alpha-glucosidase (GAA) enzyme activity assay followed by, (2) GAA gene sequencing analysis. This study examines results from the first year of screening in a large and diverse screening population. With 453,152 screened newborns, the birth prevalence and GAA enzyme activity associated with various types of Pompe disease classifications are described. The frequency of GAA gene mutations and allele variants are reported. Of 88 screen positives, 18 newborns were resolved as Pompe disease, including 2 classic infantile-onset and 16 suspected late-onset form. The c.-32-13T>G variant was the most common pathogenic mutation reported. African American and Asian/Pacific Islander newborns had higher allele frequencies for both pathogenic and pseudodeficiency variants. After the first year of Pompe disease screening in California, the disease distribution in the population is now better understood. With the ongoing long-term follow-up system currently in place, our understanding of the complex genotype-phenotype relationships will become more evident in the future, and this should help us better understand the clinical significance of identified cases.Keywords
This publication has 42 references indexed in Scilit:
- High-Throughput Assay of 9 Lysosomal Enzymes for Newborn ScreeningClinical Chemistry, 2013
- A cross-sectional single-centre study on the spectrum of Pompe disease, German patients: molecular analysis of the GAA gene, manifestation and genotype-phenotype correlationsOrphanet Journal of Rare Diseases, 2012
- Newborn Screening for Lysosomal Storage Disorders in HungaryJIMD Reports, 2012
- Later-Onset Pompe Disease: Early Detection and Early Treatment Initiation Enabled by Newborn ScreeningThe Journal of Pediatrics, 2011
- Early Detection of Pompe Disease by Newborn Screening Is Feasible: Results From the Taiwan Screening ProgramPEDIATRICS, 2008
- p.[G576S; E689K]: pathogenic combination or polymorphism in Pompe disease?European Journal of Human Genetics, 2008
- Direct multiplex assay of enzymes in dried blood spots by tandem mass spectrometry for the newborn screening of lysosomal storage disordersJournal of Inherited Metabolic Disease, 2006
- The Natural Course of Infantile Pompe’s Disease: 20 Original Cases Compared With 133 Cases From the LiteraturePEDIATRICS, 2003
- Frequency of glycogen storage disease type II in The Netherlands: implications for diagnosis and genetic counsellingEuropean Journal of Human Genetics, 1999
- The African Origin of the Common Mutation in African American Patients with Glycogen-Storage Disease Type IIAmerican Journal of Human Genetics, 1998